EDOC News and Press, Global X Telemedicine & Digital Health ETF From 12/06/23

2023-12-06 17:36:13 ET More on Edoc Acquisition Corp., Edoc Acquisition Corp. Warrants, etc. Financial information for Edoc Acquisition Corp. Financial information for Edoc Acquisition Corp. Warrants Seeking Alpha’s Quant Rating on Telemedicine & Digital H...

2023-12-04 06:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-22 02:15:00 ET Summary Q3 earnings season had many familiar refrains relative to the year’s first two quarters. One difference was a return to positive earnings growth for the first time since Q3 2022. Not unlike the first two quarters of the year, earnings for ...

2023-11-21 09:05:00 ET Summary A more volatile macroeconomic regime, alongside relatively high rates, may mean investors need to demand greater compensation for taking on equity risk; they can meet this higher performance bar by getting precise about targeted opportunities. The AI...

2023-11-17 05:55:00 ET Summary Biotech sector faces challenges including higher interest rates, inflation, regulatory pressures, and a post-COVID slump. Short interest remains high for some pharmaceutical companies, indicating bearish sentiment. Exchange-traded funds in the bi...

2023-11-15 08:16:54 ET More on Markets Oppenheimer favors tech amid upbeat prediction for S&P 500 Cathie Wood's ARK Invest launches crypto ETFs in partnership with 21Shares Nasdaq exits correction territory, small caps rebound in Russell revenge For furth...

2023-11-14 05:40:00 ET Summary Healthcare stocks have underperformed the global market this year. Investors in healthcare stocks have been disappointed in 2023. Active investors can find attractively valued companies that benefit from durable business growth trends across the ...

2023-11-03 03:30:00 ET Summary Following a strong first half of 2023, third quarter returns were more challenged across almost all asset classes. One outlier was high-yield debt, which often serves as a way to de-risk equity exposures when stocks are under pressure. Most year-...

2023-10-23 12:05:00 ET Summary U.S. corporate earnings have stagnated with the economy. We stay selective in stocks and harness mega forces like artificial intelligence as key profit centers. The 10-year U.S. Treasury yield hit 16-year highs near 5.0% last week, while U.S. stocks ...

2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...